Literature DB >> 25058759

Lobar lung resection in elderly patients with non-small cell lung carcinoma: impact of chronic obstructive pulmonary disease on surgical outcome.

O Senbaklavaci1.   

Abstract

The aim of this study was to evaluate the impact of chronic obstructive pulmonary disease (COPD) on the perioperative morbidity and mortality after lobar lung resection for non-small cell lung cancer (NSCLC) in patients aged 70 years and older. The medical records of 73 patients≥70 years who underwent lobar lung resection for NSCLC from 2003 to 2013 at our department were reviewed retrospectively. There were 27 patients with a mean age of 73.6 years and mean predicted forced expiratory volume in 1 s (FEV1) of 69.7% in the COPD group whereas remaining 46 patients (mean age=75.6 years) in the non-COPD group had a mean predicted FEV1 of 79.1%. There were no significant differences in perioperative morbidity (4.8% in the COPD group versus 17.4% in the non-COPD group) between both groups. We had no perioperative mortality in both groups. Lobar lung resection for NSCLC seems to be a safe therapy option for elderly patients with COPD who are fulfilling the common functional criteria of operability so that radical surgery should remain the mainstay of treatment for early-stage NSCLC in this increasing subpopulation.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Elderly; Lung resections; Non-small cell lung carcinoma

Mesh:

Year:  2014        PMID: 25058759      PMCID: PMC4114355          DOI: 10.9738/INTSURG-D-14-00015.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  32 in total

1.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

Review 2.  Lung cancer 7: management of lung cancer in elderly patients.

Authors:  R Booton; M Jones; N Thatcher
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

3.  Ulcerative colitis and colorectal cancer. A population-based study.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

4.  Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.

Authors:  D Provenzale; C Schmitt; J B Wong
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

5.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

6.  Surgery for elderly lung cancer.

Authors:  Hung-Chang Liu; Wen-Chien Huang; Chien-Liang Wu; Jung-Tang Huang; Chih-Hao Chen; Yu-Jen Chen
Journal:  Ann Thorac Cardiovasc Surg       Date:  2013-02-28       Impact factor: 1.520

7.  Previous lung disease and risk of lung cancer among men and women nonsmokers.

Authors:  S T Mayne; J Buenconsejo; D T Janerich
Journal:  Am J Epidemiol       Date:  1999-01-01       Impact factor: 4.897

8.  Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

Authors:  A B Lowenfels; P Maisonneuve; G Cavallini; R W Ammann; P G Lankisch; J R Andersen; E P Dimagno; A Andrén-Sandberg; L Domellöf
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

Review 9.  Health effects of cigarette smoking.

Authors:  C B Sherman
Journal:  Clin Chest Med       Date:  1991-12       Impact factor: 2.878

10.  Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease.

Authors:  Yasuo Sekine; Takekazu Iwata; Masako Chiyo; Kazuhiro Yasufuku; Shinichiro Motohashi; Shigetoshi Yoshida; Makoto Suzuki; Toshihiko Iizasa; Yukio Saitoh; Takehiko Fujisawa
Journal:  Ann Thorac Surg       Date:  2003-08       Impact factor: 4.330

View more
  1 in total

Review 1.  Outcomes of lobectomy on pulmonary function for early stage non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD).

Authors:  Sen Wei; Feng Chen; Renwang Liu; Dianxun Fu; Yanye Wang; Bo Zhang; Dian Ren; Fan Ren; Zuoqing Song; Jun Chen; Song Xu
Journal:  Thorac Cancer       Date:  2020-05-06       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.